Susan Elizabeth Arnold - 20 May 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role
VP, Preclinical and Chem
Signature
/s/ John P. Sharp, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
20 May 2021
Net transactions value
+$14,720
Form type
4
Filing time
24 May 2021, 18:09:53 UTC
Next filing
03 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $14,720 +5,257 +29% $2.80* 23,241 20 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).